These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38975330)

  • 1. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders.
    Fan L; Hu Y; Li R; Ding J; Liu Y; Yu S; Hu M; Su R; Li Y; Yu A; Xie D; Zhao Q; Ma P
    Front Cell Infect Microbiol; 2024; 14():1397743. PubMed ID: 38975330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
    Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.
    Bordoni V; Brando B; Piselli P; Forini O; Perna FE; Atripaldi U; Carputo S; Garziano F; Trento E; D'Agosto G; Latini A; Colafigli M; Cristaudo A; Sacchi A; Andreoni M; De Carli G; Orchi N; Grelli S; Gatti A; Cerva C; Minutolo A; Potestà M; Di Martino ML; Ortu F; Selva P; Del Pup L; Guarnori I; Lorenzini P; Capuano G; Antinori A; Agrati C
    PLoS One; 2019; 14(12):e0225415. PubMed ID: 31869342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Naive CD4+ T-cell Level Predicting Immune Reconstitution in Treated HIV-infected Late Presenters.
    Guo FP; Li YJ; Qiu ZF; Lv W; Han Y; Xie J; Li YL; Song XJ; Du SS; Mehraj V; Li TS; Routy JP
    Chin Med J (Engl); 2016 Nov; 129(22):2683-2690. PubMed ID: 27824000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
    Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
    Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
    Gene; 2020 May; 741():144568. PubMed ID: 32165289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.
    Lisco A; Wong CS; Lage SL; Levy I; Brophy J; Lennox J; Manion M; Anderson MV; Mejia Y; Grivas C; Mystakelis H; Burbelo PD; Perez-Diez A; Rupert A; Martens CA; Anzick SL; Morse C; Chan S; Deleage C; Sereti I
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
    Rusconi S; Vitiello P; Adorni F; Colella E; Focà E; Capetti A; Meraviglia P; Abeli C; Bonora S; D'Annunzio M; Di Biagio A; Di Pietro M; Butini L; Orofino G; Colafigli M; d'Ettorre G; Francisci D; Parruti G; Soria A; Buonomini AR; Tommasi C; Mosti S; Bai F; Di Nardo Stuppino S; Morosi M; Montano M; Tau P; Merlini E; Marchetti G
    PLoS One; 2013; 8(11):e80157. PubMed ID: 24244635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4
    Yeregui E; Masip J; Viladés C; Domingo P; Pacheco YM; Blanco J; Mallolas J; Alba V; Vargas M; García-Pardo G; Negredo E; Olona M; Vidal-González J; Peraire M; Martí A; Reverté L; Gómez-Bertomeu F; Leal M; Vidal F; Peraire J; Rull A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients.
    Lu L; Li X; Liu X; Qiu Z; Han Y; Song X; Li Y; Li X; Cao W; Lv W; Dou Z; Li T
    Aging (Albany NY); 2022 Dec; 14(23):9647-9667. PubMed ID: 36490352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment.
    Lu I; Eberhard J; Ahmad F; Bhatnagar N; Behrens G; Jacobs R; Schmidt RE; Meyer-Olson D
    Immunol Lett; 2014; 158(1-2):1-6. PubMed ID: 24291117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.
    Negredo E; Massanella M; Puig J; Pérez-Alvarez N; Gallego-Escuredo JM; Villarroya J; Villarroya F; Moltó J; Santos JR; Clotet B; Blanco J
    Clin Infect Dis; 2010 May; 50(9):1300-8. PubMed ID: 20367229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
    Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
    J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.